Opko Health OPK Pharmaceutical — Goodwill
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opko Health's pharmaceutical — goodwill.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Opko Health's pharmaceutical — goodwill?
- Opko Health (OPK) reported pharmaceutical — goodwill of $318.83M in Q1 2026.
- What is the long-term trend for Opko Health's pharmaceutical — goodwill?
- Over 3 years (2021 to 2024), Opko Health's pharmaceutical — goodwill has grown at a 13.2% compound annual growth rate (CAGR), from $863.45M to $1.25B.
- What does pharmaceutical — goodwill mean?
- The net carrying value of goodwill associated with the pharmaceutical segment after accounting for acquisitions, divestitures, and impairment charges. It serves as a key indicator of the segment's historical acquisition activity and current valuation assessment.